CPEB4 modulates liver cancer progression by translationally regulating hepcidin expression and sensitivity to ferroptosis by M. Eugenia Delgado, Salvador Naranjo-Suarez, Marta Ramírez-Pedraza, Beatriz I. Cárdenas, Carmen Gallardo-Martínez, Alexandra Balvey, Eulalia Belloc, Judit Martín, Mark Boyle, Raúl Méndez, Mercedes Fernandez

“…Background & Aims: Liver cancer is a significant global health issue, with its incidence rising in parallel with the obesity epidemic. …”
Get full text

Impact of diabetes on long-term survival in elderly liver cancer patients: A retrospective study by Chen Dan, Gao Xiaoxiao, Wang Yaqing

Subjects: Get full text

Plexin C1 Marks Liver Cancer Cells with Epithelial Phenotype and Is Overexpressed in Hepatocellular Carcinoma by Gorkem Odabas, Metin Cetin, Serdar Turhal, Huseyin Baloglu, A. Emre Sayan, Tamer Yagci

Get full text

Overview of hepatocarcinogenesis focusing on cellular origins of liver cancer stem cells: a narrative review by Jong Ryeol Eun

Subjects: Get full text

Referring clinicians’ knowledge, attitudes and practice towards international guidelines for liver cancer diagnosis in Singapore by Yi Ting Lim, Hsien Min Low, Cher Heng Tan

Get full text

Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels by Shuang Li, Shuang Li, Shuangjiang Li, Linjing Guan, Mingjuan Li, Jiahui Zhao, Min Wu, Qiuyun Li, Hui Li, Guoqing Ouyang, Guangdong Pan, Guangdong Pan

Subjects: Get full text

Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer by Lulu Sun, Chunmei Liang, Yuqin Wang, Hui Li, Lijun Yao, Huajun Jiang

Subjects: Get full text

Identification of CD8+ T Cell-Related Genes: Correlations with Immune Phenotypes and Outcomes of Liver Cancer by Qi Pan, Ying Cheng, Donghua Cheng

“…Treatment outcomes for advanced liver cancer are poor. Immunotherapy is a treatment strategy that has been widely used to treat other cancers. …”
Get full text

Ascorbic acid-immobilized zinc selenide for electrochemical monitoring of hydrogen peroxide in liver cancer samples by Shan E Zahra Jawad, Sibtain Ahmed, Dilshad Hussain, Javerya Najeeb, Ayub Alam, Muhammad Najam-ul-Haq, Batool Fatima

“…Abstract Liver cancer is globally the most frequent fatal malignancy, and its identification is critical for making clinical decisions about treatment options. …”
Get full text

A meta-analysis of the value of indocyanine green fluorescence imaging in guiding surgical resection of primary and metastatic liver cancer by Dali Xiong, Jiaran Li, Li Li, Fuhao Xu, Tao Hu, He Zhu, Xiaohui Xu, Yawen Sun, Shuanghu Yuan

Subjects: Get full text

Succinate supplementation alleviates liver cancer by inhibiting the FN1/SQLE axis-mediated cholesterol biosynthesis by Shuyuan Chang, Ayaka Tomii, Yunfei Zhou, Xun Yang, Yihong Dong, Jun Yan, Aodi Wu, Yumeng Wang, Qingxin Zhang, Hongxue Meng, Lei Yu, Wei Sun, Dabin Liu

“…Succinate supplementation exhibits an anti-tumorigenic effect, inhibiting cell proliferation and colony formation in liver cancer cells but not in non-tumor LO2 cells. Additionally, succinate supplementation significantly reduces tumor formation in xenograft nude mice models and carcinogen-induced WT mice models. …”
Get full text

Molecular dynamics simulation based prediction of T-cell epitopes for the production of effector molecules for liver cancer immunotherapy. by Sidra Zafar, Yuhe Bai, Syed Aun Muhammad, Jinlei Guo, Haris Khurram, Saba Zafar, Iraj Muqaddas, Rehan Sadiq Shaikh, Baogang Bai

“…Liver cancer is the sixth most frequent malignancy and the fourth major cause of deaths worldwide. …”
Get full text

Poly lactic‐co‐glycolic acid‐alginate nanocarrier for efficient drug delivery to liver cancer cells by Mahsa Hoseinzadeh, Mohammad Javad Mokhtari, Farshid Kafilzadeh, Javad Mohammadnejad, Yaghoob Taheri

“…Abstract Efficient drug delivery systems (DDSs) can potentially replace with conventional modalities in cancer therapy, like liver cancer. In this study, a novel folic acid (FA)‐functionalised and alginate (Alg)‐modified poly lactic‐co‐glycolic acid (PLGA) nanocomposite was developed for delivery of doxorubicin (Dox) to HepG2 and Huh7 liver cancer cells. …”
Get full text

The role of artificial intelligence and image processing in the diagnosis, treatment, and prognosis of liver cancer: a narrative-review by Platon Dimopoulos, Admir Mulita, Andreas Antzoulas, Sylvain Bodard, Vasileios Leivaditis, Ioanna Akrida, Nikolaos Benetatos, Konstantinos Katsanos, Christos-Nikolaos Anagnostopoulos, Francesk Mulita

Subjects: “…liver cancer…”
Get full text

FIRST RUSSIAN EXPERIENCE OF USING THE INTEGRATED SYSTEM OF LASER THERMOABLATION THERAPY IN THE TREATMENT OF METASTATIC LIVER CANCER by D. V. Sidorov, S. O. Stepanov, M. V. Lozhkin, L. O. Petrov, O. V. Gutz, A. A. Kostin, A. G. Isaeva

“…Extensive liver resections are the main method of treatment of patients with primary and metastatic liver cancer, which allows the noticeable prolongation of life. …”
Get full text

Thermal ablation enhances immunotherapeutic effect of IP-001 on orthotopic liver cancer in a rat model by Yan Li, Samuel S.K. Lam, Chun Fung Wong, Tomas Hode, David Anderson, Robert C.G. Martin

Get full text

A five-plex Hepatic Oncochip reveals EMT triplet correlated with BAP31 in liver cancer by Youjia Kong, Youjia Kong, Tengfei Zhuang, Xvshen Ding, Xvshen Ding, Sirui Cai, Weijie Ding, Xiaoxiao Zhang, Yubo Sun, Bingquan Zhou, Yuanjie Sun, Shuya Yang, Xiyang Zhang, Xiyang Zhang, Kun Yang, Kun Yang, Dongbo Jiang, Dongbo Jiang

Subjects: “…liver cancer…”
Get full text

Anti-Tumor Effects of <i>Vespa bicolor</i> Venom on Liver Cancer: In Vitro and In Vivo Studies by Yong-Hua Wu, Feng Xiong, Zheng-Wen Ou, Jing-An Wang, Jing Cui, Lin Jiang, Wen-Jian Lan

“…This study is the first to examine the anti-tumor effects of VBV on liver cancer, both alone and in combination with cisplatin (DDP), through in vitro and in vivo experiments. …”
Get full text

Liver Radioembolization: a New Chapter in Russian Oncology by A. D. Kaprin, S. A. Ivanov, V. V. Kucherov, A. P. Petrosyan, K. V. Mayorov, N. V. Markov, L. O. Petrov, G. A. Davydov, M. A. Sigov, N. K. Silantieva, T. P. Berezovskaya, A. Yu. Usacheva, D. B. Sanin

Subjects: “…liver cancer…”
Get full text

Circle-seq reveals that eccDNA may be a key blood biomarker for HBV-associated liver cancer by Xiao K. Ran, Xiao F. Zhao, Zhen W. Wei, Hua Z. Pang, Yan F. Tang, Rong Liu, Tie X. Wu, Xu D. Liu

“…Experiments have verified that LAMA4[circle112550019-112550510] and KANK1[circle674459-674907] are real and expressed target genes, and their source genes are closely related to the survival time of patients with liver cancer.ConclusionOur research results revealed the main characteristics of eccDNAs in the blood of patients with HBV-related HCC and LC. …”
Get full text